PMID: 11606023Oct 19, 2001Paper

Modulation of Th2 type cytokine production from human peripheral blood leukocytes by a macrolide antibiotic, roxithromycin, in vitro

International Immunopharmacology
K AsanoHarumi Suzaki

Abstract

The influence of a macrolide antibiotic, roxithromycin (RXM), on Th1 and Th2 cytokine productions from human peripheral blood T cells was examined under stimulation with co-stimulatory molecules. Peripheral blood T cells prepared from both healthy and allergic rhinitis donors were cultured in the presence of RXM on anti-CD3 mAb and anti-CD26 mAb-coated wells, anti-CD3 mAb and anti-CD28 mAb-coated wells, and anti-CD3 and PMA. T-cell proliferation, along with the concentration of interleukin (IL)-2, interferon (IFN)-gamma, IL-4 and IL-5 were measured. RXM did not affect T-cell proliferation induced by several ways of co-stimulatory activation as assessed by 3H-thymidine incorporation into DNA. RXM also had no effect on IL-2 and IFN-gamma secretion by T cells prepared from both healthy and allergic rhinitis donors. On the other hand, RXM markedly inhibited both IL-4 and IL-5 secretions under each of the co-stimulatory conditions in a dose-dependent manner. These results indicate that RXM inhibits specifically Th2 cytokine secretion from T cells induced by co-stimulatory molecule stimulations. This inhibitory action of RXM may be partially responsible for attenuating effect of the agent on the inflammatory diseases.

References

Dec 1, 1992·Immunology Today·C J Corrigan, A B Kay
Jan 1, 1992·Life Sciences·S KonnoT Takahashi
Aug 1, 1991·Immunology Today·S Romagnani
Jan 1, 1991·Respiration; International Review of Thoracic Diseases·H NagaiA Kurashima
Jan 1, 1991·International Archives of Allergy and Applied Immunology·A B Kay
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·T J Novak, E V Rothenberg
Jun 1, 1988·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A Naess, C O Solberg
Mar 1, 1970·The Journal of Allergy·I H Itkin, M L Menzel
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T TanakaC Morimoto
Nov 1, 1994·International Archives of Allergy and Immunology·S KonnoM Adachi
Jan 1, 1994·Annual Review of Immunology·S Romagnani
Jan 1, 1994·Allergy·P Venge
Jan 1, 1993·Cancer Investigation·S Mahanty, T B Nutman
Jan 1, 1993·The American Review of Respiratory Disease·J KadotaK Hara
Jan 1, 1996·Annual Review of Immunology·D J LenschowJ A Bluestone
Jan 1, 1996·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A J Frew
Jun 1, 1997·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·M Worm, B M Henz
May 4, 1999·International Archives of Allergy and Immunology·O M Kon, A B Kay
Aug 24, 1999·Immunology and Cell Biology·N L Harris, F Ronchese
Nov 9, 2000·Immunology Today·J RengarajanL H Glimcher

❮ Previous
Next ❯

Citations

Jul 9, 2010·Clinical Microbiology Reviews·Soichiro Kanoh, Bruce K Rubin
Jul 11, 2012·Mediators of Inflammation·Helen C SteelCharles Feldman
Dec 2, 2006·International Journal of Pediatric Otorhinolaryngology·Yoshiya IshidaYasuaki Harabuchi
Nov 3, 2009·Immunology and Allergy Clinics of North America·Richard J HarveyValerie J Lund
Feb 22, 2008·Pharmacology & Therapeutics·Masaharu ShinkaiBruce K Rubin
Sep 13, 2005·Paediatric Respiratory Reviews·Masaharu Shinkai, Bruce K Rubin
Mar 3, 2009·Journal of Dermatological Science·Taisuke ItoMasahiro Takigawa
Jan 7, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Janvier Engelbert AgbokpontoLi Ding
Jan 25, 2007·Inflammatory Bowel Diseases·Hiroshi TamagawaHiroshi Kiyono
May 21, 2011·International Archives of Allergy and Immunology·Syh-Jae LinMing-Ling Kuo
Aug 17, 2005·The Journal of Pharmacy and Pharmacology·Ken-Ichi KanaiHarumi Suzaki
Dec 8, 2009·Archivos de bronconeumología·Daniel Sevilla-SánchezNéstor Soler-Porcar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.